Profil bibliographique

Mercedes Rodríguez-Garrote

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

57Publications signalées

478Citations signalées

2Affiliations récentes

Institutions déclarées

Instituto Cajal Instituto Ramón y Cajal de Investigación Sanitaria

Domaines associés

Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCancer Cells and MetastasisCancer-related molecular mechanisms researchExtracellular vesicles in disease

Publications récentes

2026 articleOpenAlex

A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study

Jiangchuan He, Sergio Sabroso-Lasa, Claudia Coscia, Evangelina López de Maturana et autres

0 citationsCancer Epidemiology Biomarkers & Prevention

Accès ouvert 2026 erratumOpenAlex

Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis

Alberto Langtry, Raul Rabadan, Lola Alonso, Ioan Alexandru Filip et autres

0 citationsNature Communications

Accès ouvert 2025 articleOpenAlex

Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis

Alberto Langtry, Raúl Rabadán, Lola Alonso, Ioan Filip et autres

4 citationsNature Communications

Accès ouvert 2025 conference-paperOpenAlex

530 CD40 agonist mitazalimab + mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma: dose characterization based on exposure response and biomarker analysis from the OPTIMIZE-1 study

Emmanuel Mitry, Teresa Macarulla, I. Gallego Jiménez, Roberto Pazo-Cid et autres

0 citationsRegular and Young Investigator Award Abstracts

Accès ouvert 2025 articleOpenAlex

Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

Florian Castet, Carles Fabregat-Franco, John Bridgewater, Jin Won Kim et autres

4 citationsJournal of Hepatology

Accès ouvert 2024 articleOpenAlex

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study

Joan Llach, Irina Luzko, Julie Earl, Emma Barreto et autres

3 citationsCancers

Accès ouvert 2024 conference-paperOpenAlex

592 CD40 agonist mitazalimab combined with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): updated efficacy and correlative biomarkers from the OPTIMIZE-1 trial

Karen Geboes, Gregory L. Beatty, Ivan Borbath, Teresa Macarulla et autres

0 citationsRegular and Young Investigator Award Abstracts

Accès ouvert 2024 articleOpenAlex

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

Juan Carlos; https://orcid.org/0000-0003-4988-8648 López-Gil, Susana; https://orcid.org/0000-0003-1065-0245 García-Silva, Laura Ruiz-Cañas, Diego Navarro et autres

0 citationsZurich Open Repository and Archive (University of Zurich)

Accès ouvert 2024 articleOpenAlex

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

Juan Carlos López-Gil, Susana Garcı́a-Silva, Laura Ruíz-Cañas, Diego Navarro et autres

20 citationsGut

Accès ouvert 2024 articleOpenAlex

Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer

Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, Javier Gállego et autres

26 citationsNEJM Evidence

Accès ouvert 2024 preprintOpenAlex

Safety, Efficacy, and Biomarker Results of a Phase 1b/2 Study Combining the CD40 Agonist Mitazalimab with mFOLFIRINOX in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC); Results of the OPTIMIZE-1 Trial

Jean‐Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Geboes et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2024 preprintOpenAlex

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study

Joan Llach, Irina Luzko, Julie Earl, Emma Barreto et autres

1 citationSSRN Electronic Journal

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.